Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs in Adult Liver Cirrhosis
NCT05331872Phase 1Completed
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Jan 2021
- Primary completion
- Sep 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human umbilical cord derived mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Primary endpoint: Number of Adverse events and serious adverse events at 12 months. Started Jan 2021; status: completed.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05331872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331872.